Roche Unit To Buy Rival's Patient Test Portfolio For $295M
A subsidiary of Swiss drugmaker Roche has agreed to buy parts of diagnostic platform LumiraDx Ltd. for $295 million as it eyes growth in the sector, the medical technology business said...To view the full article, register now.
Already a subscriber? Click here to view full article